Submitted:
02 December 2024
Posted:
03 December 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. New Framework for the Relationship Between Protein Folding and Aggregation
3. Relationship Between Misfolding and Aggregation
4. Relationship Between Anfinsen’s Thermodynamic Hypothesis and Aggregation
5. Relationship Between Molecular Chaperones and Aggregation
5.1. Independence Between Direct and Indirect Protein Folding Assistance of Molecular Chaperones
5.2. GroEL/ES Chamber: Delineating Independence Between Protein Folding and Aggregation
5.3. Overlooked Aspects of the Complex Cellular Milieu in the Molecular Chaperone Concept
6. Generic Intrinsic Chaperone-Like Activities of Cellular Macromolecules: Their Independent Effects on Protein Folding and Aggregation
6.1. Independent Effects of Macromolecular Tethering on Protein Folding and Aggregation
6.2. Biological Relevance and Significance of Protein Fusion Approaches
6.3. Artificial Chaperone System: Conversion of a Soluble Protein into a Potent Chaperone
7. Aggregation Inhibition by Structure-Destabilizing Intermolecular Repulsive Forces
7.1. Pitfalls of Modern Protein Science
7.2. Structure-Destabilizing Intermolecular Repulsive Forces in Protein Folding
7.3. Role of Intermolecular Repulsive Forces in Aggregation Inhibition
7.4. The Role of Intermolecular Repulsive Forces in the Substrate Stabilization by Molecular Chaperones
8. Metastability Revisited Through the New Framework
8.1. Strategies for Decreasing the Effective Concentration of Shared Aggregation Monomers
8.2. Thermodynamic Destabilization of Aggregates by Physical Linkage of Cellular Macromolecules
9. Applications of the New Framework to Therapeutic Interventions for Proteinopathies
9.1. Targeting Cellular Macromolecules as Drug Candidates in Proteinopathies
9.2. Cellular Macromolecules as Native Interactors: Promising Drug Targets in Proteinopathies
10. Conclusions and Future Perspectives
Author Contributions
Funding
Institutional Review Board Statement
Conflicts of Interest
References
- Hartl, F.U.; Bracher, A.; Hayer-Hartl, M. Molecular chaperones in protein folding and proteostasis. Nature 2011, 475, 324–332. [Google Scholar] [CrossRef] [PubMed]
- Vendruscolo, M.; Knowles, T.P.; Dobson, C.M. Protein solubility and protein homeostasis: A generic view of protein misfolding disorders. Cold Spring Harb Perspect Biol 2011, 3, a010454. [Google Scholar] [CrossRef] [PubMed]
- Choi, S.I.; Seong, B.L. A social distancing measure governing the whole proteome. Curr Opin Struct Biol 2021, 66, 104–111. [Google Scholar] [CrossRef] [PubMed]
- Chiti, F.; et al. Kinetic partitioning of protein folding and aggregation. Nat Struct Biol 2002, 9, 137–143. [Google Scholar] [CrossRef]
- Sabate, R.; de Groot, N.S.; Ventura, S. Protein folding and aggregation in bacteria. Cell Mol Life Sci 2010, 67, 2695–2715. [Google Scholar] [CrossRef]
- Baldwin, A.J.; et al. Metastability of native proteins and the phenomenon of amyloid formation. J Am Chem Soc 2011, 133, 14160–14163. [Google Scholar] [CrossRef]
- Farzadfard, A.; et al. Thermodynamic characterization of amyloid polymorphism by microfluidic transient incomplete separation. Chem Sci 2024, 15, 2528–2544. [Google Scholar] [CrossRef]
- Ellis, R.J.; Hartl, F.U. Principles of protein folding in the cellular environment. Curr Opin Struct Biol 1999, 9, 102–110. [Google Scholar] [CrossRef]
- Frydman, J. Folding of newly translated proteins in vivo: The role of molecular chaperones. Annu Rev Biochem 2001, 70, 603–647. [Google Scholar] [CrossRef]
- Hartl, F.U.; Hayer-Hartl, M. Molecular chaperones in the cytosol: From nascent chain to folded protein. Science 2002, 295, 1852–1858. [Google Scholar] [CrossRef]
- Bukau, B.; Horwich, A.L. The Hsp70 and Hsp60 chaperone machines. Cell 1998, 92, 351–366. [Google Scholar] [CrossRef] [PubMed]
- Balch, W.E.; Morimoto, R.I.; Dillin, A.; Kelly, J.W. Adapting proteostasis for disease intervention. Science 2008, 319, 916–919. [Google Scholar] [CrossRef] [PubMed]
- Muchowski, P.J.; Wacker, J.L. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 2005, 6, 11–22. [Google Scholar] [CrossRef] [PubMed]
- Kraft, F.; et al. Brain malformations and seizures by impaired chaperonin function of TRiC. Science 2024, 386, 516–525. [Google Scholar] [CrossRef]
- Vendruscolo, M. Proteome folding and aggregation. Curr Opin Struct Biol 2012, 22, 138–143. [Google Scholar] [CrossRef]
- Chiti, F.; Dobson, C.M. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu Rev Biochem 2017, 86, 27–68. [Google Scholar] [CrossRef]
- Valastyan, J.S.; Lindquist, S. Mechanisms of protein-folding diseases at a glance. Dis Model Mech 2014, 7, 9–14. [Google Scholar] [CrossRef]
- Knowles, T.P.; Vendruscolo, M.; Dobson, C.M. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol 2014, 15, 384–396. [Google Scholar] [CrossRef]
- Hartl, F.U. Protein Misfolding Diseases. Annu Rev Biochem 2017, 86, 21–26. [Google Scholar] [CrossRef]
- Anfinsen, C.B. Principles that govern the folding of protein chains. Science 1973, 181, 223–230. [Google Scholar] [CrossRef]
- Gazit, E. The “Correctly Folded” state of proteins: Is it a metastable state? Angew Chem Int Ed Engl 2002, 41, 257–259. [Google Scholar] [CrossRef] [PubMed]
- Varela, A.E.; et al. Kinetic Trapping of Folded Proteins Relative to Aggregates under Physiologically Relevant Conditions. J Phys Chem B 2018, 122, 7682–7698. [Google Scholar] [CrossRef] [PubMed]
- Noji, M.; et al. Breakdown of supersaturation barrier links protein folding to amyloid formation. Commun Biol 2021, 4, 120. [Google Scholar] [CrossRef] [PubMed]
- Riek, R.; Eisenberg, D.S. The activities of amyloids from a structural perspective. Nature 2016, 539, 227–235. [Google Scholar] [CrossRef]
- Thirumalai, D.; Reddy, G. Protein thermodynamics: Are native proteins metastable? Nat Chem 2011, 3, 910–911. [Google Scholar] [CrossRef]
- Chiti, F.; Stefani, M.; Taddei, N.; Ramponi, G.; Dobson, C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 2003, 424, 805–808. [Google Scholar] [CrossRef]
- Wang, W.; Nema, S.; Teagarden, D. Protein aggregation--pathways and influencing factors. Int J Pharm 2010, 390, 89–99. [Google Scholar] [CrossRef]
- Dee, D.R.; Woodside, M.T. Comparing the energy landscapes for native folding and aggregation of PrP. Prion 2016, 10, 207–220. [Google Scholar] [CrossRef]
- Louros, N.; Schymkowitz, J.; Rousseau, F. Mechanisms and pathology of protein misfolding and aggregation. Nat Rev Mol Cell Biol 2023, 24, 912–933. [Google Scholar] [CrossRef]
- Frey, L.; et al. A structural rationale for reversible vs irreversible amyloid fibril formation from a single protein. Nat Commun 2024, 15, 8448. [Google Scholar] [CrossRef]
- Choi, S.I. A Simple Principle for Understanding the Combined Cellular Protein Folding and Aggregation. Curr Protein Pept Sci 2020, 21, 3–21. [Google Scholar] [CrossRef] [PubMed]
- Choi, S.I.; Seong, B.L. A Conceptual Framework for Integrating Cellular Protein Folding, Misfolding and Aggregation. Life (Basel) 2021, 11, 605. [Google Scholar] [CrossRef] [PubMed]
- Shaw, K.L.; Grimsley, G.R.; Yakovlev, G.I.; Makarov, A.A.; Pace, C.N. The effect of net charge on the solubility, activity, and stability of ribonuclease Sa. Protein Sci 2001, 10, 1206–1215. [Google Scholar] [CrossRef] [PubMed]
- Schmittschmitt, J.P.; Scholtz, J.M. The role of protein stability, solubility, and net charge in amyloid fibril formation. Protein Sci 2003, 12, 2374–2378. [Google Scholar] [CrossRef]
- Zhou, H.X.; Pang, X. Electrostatic Interactions in Protein Structure, Folding, Binding, and Condensation. Chem Rev 2018, 118, 1691–1741. [Google Scholar] [CrossRef]
- Wennerstrom, H.; Estrada, E.V.; Danielsson, J.; Oliveberg, M. Colloidal stability of the living cell. Proc Natl Acad Sci U S A 2020, 117, 10113–10121. [Google Scholar] [CrossRef]
- Zhong, L.; Fu, S.; Peng, X.; Zhan, H.; Sun, R. Colloidal stability of negatively charged cellulose nanocrystalline in aqueous systems. Carbohydr Polym 2012, 90, 644–649. [Google Scholar] [CrossRef]
- Kurnik, M.; Hedberg, L.; Danielsson, J.; Oliveberg, M. Folding without charges. Proc Natl Acad Sci U S A 2012, 109, 5705–5710. [Google Scholar] [CrossRef]
- Houben, B.; Rousseau, F.; Schymkowitz, J. Protein structure and aggregation: A marriage of necessity ruled by aggregation gatekeepers. Trends Biochem Sci 2022, 47, 194–205. [Google Scholar] [CrossRef]
- Oldfield, C.J.; Dunker, A.K. Intrinsically disordered proteins and intrinsically disordered protein regions. Annu Rev Biochem 2014, 83, 553–584. [Google Scholar] [CrossRef]
- Dunker, A.K.; et al. The unfoldomics decade: An update on intrinsically disordered proteins. BMC Genomics 2008, 9 (Suppl. S2), S1. [Google Scholar] [CrossRef] [PubMed]
- Uversky, V.N. Unusual biophysics of intrinsically disordered proteins. Biochim Biophys Acta 2013, 1834, 932–951. [Google Scholar] [CrossRef] [PubMed]
- Choi, S.I.; Ryu, K.; Seong, B.L. RNA-mediated chaperone type for de novo protein folding. RNA Biol 2009, 6, 21–24. [Google Scholar] [CrossRef]
- Choi, S.I.; Lim, K.H.; Seong, B.L. Chaperoning roles of macromolecules interacting with proteins in vivo. Int J Mol Sci 2011, 12, 1979–1990. [Google Scholar] [CrossRef]
- Choi, S.I.; et al. Protein folding in vivo revisited. Curr Protein Pept Sci 2013, 14, 721–733. [Google Scholar] [CrossRef]
- Hipp, M.S.; Park, S.H.; Hartl, F.U. Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends Cell Biol 2014, 24, 506–514. [Google Scholar] [CrossRef]
- Fink, A.L. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 1998, 3, R9–R23. [Google Scholar] [CrossRef]
- Horwich, A. Protein aggregation in disease: A role for folding intermediates forming specific multimeric interactions. J Clin Invest 2002, 110, 1221–1232. [Google Scholar] [CrossRef]
- Fawzi, N.L.; Chubukov, V.; Clark, L.A.; Brown, S.; Head-Gordon, T. Influence of denatured and intermediate states of folding on protein aggregation. Protein Sci 2005, 14, 993–1003. [Google Scholar] [CrossRef]
- Jahn, T.R.; Radford, S.E. Folding versus aggregation: Polypeptide conformations on competing pathways. Arch Biochem Biophys 2008, 469, 100–117. [Google Scholar] [CrossRef]
- Neudecker, P.; et al. Structure of an intermediate state in protein folding and aggregation. Science 2012, 336, 362–366. [Google Scholar] [CrossRef] [PubMed]
- Hevehan, D.L.; De Bernardez Clark, E. Oxidative renaturation of lysozyme at high concentrations. Biotechnol Bioeng 1997, 54, 221–230. [Google Scholar] [CrossRef]
- Dong, X.Y.; Shi, G.Q.; Li, W.; Sun, Y. Modeling and simulation of fed-batch protein refolding process. Biotechnol Prog 2004, 20, 1213–1219. [Google Scholar] [CrossRef] [PubMed]
- Munoz, V.; et al. Folding and aggregation kinetics of a beta-hairpin. Biochemistry 2006, 45, 7023–7035. [Google Scholar] [CrossRef]
- Rudiger, S.; Germeroth, L.; Schneider-Mergener, J.; Bukau, B. Substrate specificity of the DnaK chaperone determined by screening cellulose-bound peptide libraries. EMBO J 1997, 16, 1501–1507. [Google Scholar] [CrossRef]
- Fink, A.L. Chaperone-mediated protein folding. Physiol Rev 1999, 79, 425–449. [Google Scholar] [CrossRef]
- Lawrence, M.S.; Phillips, K.J.; Liu, D.R. Supercharging proteins can impart unusual resilience. J Am Chem Soc 2007, 129, 10110–10112. [Google Scholar] [CrossRef]
- Minton, A.P. Implications of macromolecular crowding for protein assembly. Curr Opin Struct Biol 2000, 10, 34–39. [Google Scholar] [CrossRef]
- Andrews, J.M.; Roberts, C.J. A Lumry-Eyring nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated unfolding. J Phys Chem B 2007, 111, 7897–7913. [Google Scholar] [CrossRef]
- Li, Y.; Roberts, C.J. Lumry-Eyring nucleated-polymerization model of protein aggregation kinetics. 2. Competing growth via condensation and chain polymerization. J Phys Chem B 2009, 113, 7020–7032. [Google Scholar] [CrossRef]
- Bryngelson, J.D.; Onuchic, J.N.; Socci, N.D.; Wolynes, P.G. Funnels, pathways, and the energy landscape of protein folding: A synthesis. Proteins 1995, 21, 167–195. [Google Scholar] [CrossRef] [PubMed]
- Zheng, W.; Schafer, N.P.; Wolynes, P.G. Frustration in the energy landscapes of multidomain protein misfolding. Proc Natl Acad Sci U S A 2013, 110, 1680–1685. [Google Scholar] [CrossRef] [PubMed]
- Yu, H.; et al. Protein misfolding occurs by slow diffusion across multiple barriers in a rough energy landscape. Proc Natl Acad Sci U S A 2015, 112, 8308–8313. [Google Scholar] [CrossRef]
- Imamoglu, R.; Balchin, D.; Hayer-Hartl, M.; Hartl, F.U. Bacterial Hsp70 resolves misfolded states and accelerates productive folding of a multi-domain protein. Nat Commun 2020, 11, 365. [Google Scholar] [CrossRef]
- Balchin, D.; Hayer-Hartl, M.; Hartl, F.U. Recent advances in understanding catalysis of protein folding by molecular chaperones. FEBS Lett 2020, 594, 2770–2781. [Google Scholar] [CrossRef]
- Thirumalai, D.; Lorimer, G.H.; Hyeon, C. Iterative annealing mechanism explains the functions of the GroEL and RNA chaperones. Protein Sci 2020, 29, 360–377. [Google Scholar] [CrossRef]
- Jackson, S.E. How do small single-domain proteins fold? Fold Des 1998, 3, R81–R91. [Google Scholar] [CrossRef]
- Dobson, C.M. Protein folding and misfolding. Nature 2003, 426, 884–890. [Google Scholar] [CrossRef]
- Strodel, B.; Whittleston, C.S.; Wales, D.J. Thermodynamics and kinetics of aggregation for the GNNQQNY peptide. J Am Chem Soc 2007, 129, 16005–16014. [Google Scholar] [CrossRef]
- Nelson, R.; et al. Structure of the cross-beta spine of amyloid-like fibrils. Nature 2005, 435, 773–778. [Google Scholar] [CrossRef]
- Silow, M.; Oliveberg, M. Transient aggregates in protein folding are easily mistaken for folding intermediates. Proc Natl Acad Sci U S A 1997, 94, 6084–6086. [Google Scholar] [CrossRef] [PubMed]
- Apetri, A.C.; Horwich, A.L. Chaperonin chamber accelerates protein folding through passive action of preventing aggregation. Proc Natl Acad Sci U S A 2008, 105, 17351–17355. [Google Scholar] [CrossRef]
- Brunori, M. From Kuru to Alzheimer: A personal outlook. Protein Sci 2021, 30, 1776–1792. [Google Scholar] [CrossRef]
- Cobb, N.J.; Surewicz, W.K. Prion diseases and their biochemical mechanisms. Biochemistry 2009, 48, 2574–2585. [Google Scholar] [CrossRef]
- Pace, C.N. The stability of globular proteins. CRC Crit Rev Biochem 1975, 3, 1–43. [Google Scholar] [CrossRef]
- Goto, Y.; Nakajima, K.; Yamamoto, S.; Yamaguchi, K. Supersaturation, a Critical Factor Underlying Proteostasis of Amyloid Fibril Formation. J Mol Biol 2024, 436, 168475. [Google Scholar] [CrossRef]
- Marinelli, P.; et al. Global Protein Stabilization Does Not Suffice to Prevent Amyloid Fibril Formation. ACS Chem Biol 2018, 13, 2094–2105. [Google Scholar] [CrossRef]
- Bigman, L.S.; Levy, Y. Proteins: Molecules defined by their trade-offs. Curr Opin Struct Biol 2020, 60, 50–56. [Google Scholar] [CrossRef]
- Anfinsen, C.B.; Haber, E. Studies on the reduction and re-formation of protein disulfide bonds. J Biol Chem 1961, 236, 1361–1363. [Google Scholar] [CrossRef]
- Hartl, F.U. Chaperone-assisted protein folding: The path to discovery from a personal perspective. Nat Med 2011, 17, 1206–1210. [Google Scholar] [CrossRef]
- Hayer-Hartl, M.; Bracher, A.; Hartl, F.U. The GroEL-GroES Chaperonin Machine: A Nano-Cage for Protein Folding. Trends Biochem Sci 2016, 41, 62–76. [Google Scholar] [CrossRef] [PubMed]
- Georgescauld, F.; et al. GroEL/ES chaperonin modulates the mechanism and accelerates the rate of TIM-barrel domain folding. Cell 2014, 157, 922–934. [Google Scholar] [CrossRef] [PubMed]
- Singh, A.K.; Balchin, D.; Imamoglu, R.; Hayer-Hartl, M.; Hartl, F.U. Efficient Catalysis of Protein Folding by GroEL/ES of the Obligate Chaperonin Substrate MetF. J Mol Biol 2020, 432, 2304–2318. [Google Scholar] [CrossRef] [PubMed]
- Stenberg, G.; Fersht, A.R. Folding of barnase in the presence of the molecular chaperone SecB. J Mol Biol 1997, 274, 268–275. [Google Scholar] [CrossRef]
- Tsurupa, G.P.; Ikura, T.; Makio, T.; Kuwajima, K. Refolding kinetics of staphylococcal nuclease and its mutants in the presence of the chaperonin GroEL. J Mol Biol 1998, 277, 733–745. [Google Scholar] [CrossRef]
- Agashe, V.R.; et al. Function of trigger factor and DnaK in multidomain protein folding: Increase in yield at the expense of folding speed. Cell 2004, 117, 199–209. [Google Scholar] [CrossRef]
- Jones, H.; Preuss, M.; Wright, M.; Miller, A.D. The mechanism of GroEL/GroES folding/refolding of protein substrates revisited. Org Biomol Chem 2006, 4, 1223–1235. [Google Scholar] [CrossRef]
- Marchenko, N.Y.; Marchenkov, V.V.; Semisotnov, G.V.; Finkelstein, A.V. Strict experimental evidence that apo-chaperonin GroEL does not accelerate protein folding, although it does accelerate one of its steps. Proc Natl Acad Sci U S A 2015, 112, E6831–E6832. [Google Scholar] [CrossRef]
- Stull, F.; Koldewey, P.; Humes, J.R.; Radford, S.E.; Bardwell, J.C.A. Substrate protein folds while it is bound to the ATP-independent chaperone Spy. Nat Struct Mol Biol 2016, 23, 53–58. [Google Scholar] [CrossRef]
- Huang, C.; Rossi, P.; Saio, T.; Kalodimos, C.G. Structural basis for the antifolding activity of a molecular chaperone. Nature 2016, 537, 202–206. [Google Scholar] [CrossRef]
- Korobko, I.; Mazal, H.; Haran, G.; Horovitz, A. Measuring protein stability in the GroEL chaperonin cage reveals massive destabilization. Elife 2020, 9, e56511. [Google Scholar] [CrossRef] [PubMed]
- Macosek, J.; Mas, G.; Hiller, S. Redefining Molecular Chaperones as Chaotropes. Front Mol Biosci 2021, 8, 683132. [Google Scholar] [CrossRef] [PubMed]
- Finka, A.; Mattoo, R.U.; Goloubinoff, P. Experimental Milestones in the Discovery of Molecular Chaperones as Polypeptide Unfolding Enzymes. Annu Rev Biochem 2016, 85, 715–742. [Google Scholar] [CrossRef]
- Hartl, F.U.; Hlodan, R.; Langer, T. Molecular chaperones in protein folding: The art of avoiding sticky situations. Trends Biochem Sci 1994, 19, 20–25. [Google Scholar] [CrossRef]
- Mayer, M.P.; et al. Multistep mechanism of substrate binding determines chaperone activity of Hsp70. Nat Struct Biol 2000, 7, 586–593. [Google Scholar]
- Horwich, A.L.; Apetri, A.C.; Fenton, W.A. The GroEL/GroES cis cavity as a passive anti-aggregation device. FEBS Lett 2009, 583, 2654–2662. [Google Scholar] [CrossRef]
- Hoffmann, A.; Bukau, B.; Kramer, G. Structure and function of the molecular chaperone Trigger Factor. Biochim Biophys Acta 2010, 1803, 650–661. [Google Scholar] [CrossRef]
- Mattoo, R.U.; Goloubinoff, P. Molecular chaperones are nanomachines that catalytically unfold misfolded and alternatively folded proteins. Cell Mol Life Sci 2014, 71, 3311–3325. [Google Scholar] [CrossRef]
- Kawagoe, S.; Ishimori, K.; Saio, T. Structural and Kinetic Views of Molecular Chaperones in Multidomain Protein Folding. Int J Mol Sci 2022, 23, 2485. [Google Scholar] [CrossRef]
- Litberg, T.J.; Horowitz, S. Roles of Nucleic Acids in Protein Folding, Aggregation, and Disease. ACS Chem Biol 2024, 19, 809–823. [Google Scholar] [CrossRef]
- Begeman, A.; et al. G-Quadruplexes act as sequence-dependent protein chaperones. EMBO Rep 2020, 21, e49735. [Google Scholar] [CrossRef] [PubMed]
- Wu, K.; Minshull, T.C.; Radford, S.E.; Calabrese, A.N.; Bardwell, J.C.A. Trigger factor both holds and folds its client proteins. Nat Commun 2022, 13, 4126. [Google Scholar] [CrossRef] [PubMed]
- Son, A.; Cabral, V.H.; Huang, Z.; Litberg, T.J.; Horowitz, S. G-quadruplexes rescuing protein folding. Proc Natl Acad Sci U S A 2023, 120, e2216308120. [Google Scholar] [CrossRef]
- Rutledge, B.S.; Choy, W.Y.; Duennwald, M.L. Folding or holding?-Hsp70 and Hsp90 chaperoning of misfolded proteins in neurodegenerative disease. J Biol Chem 2022, 298, 101905. [Google Scholar] [CrossRef]
- Ellis, R.J. Molecular chaperones. Opening and closing the Anfinsen cage. Curr Biol 1994, 4, 633–635. [Google Scholar] [CrossRef]
- Ellis, R.J. The general concept of molecular chaperones. Philos Trans R Soc Lond B Biol Sci 1993, 339, 257–261. [Google Scholar]
- Das, D.; et al. Role of the ribosome in protein folding. Biotechnol J 2008, 3, 999–1009. [Google Scholar] [CrossRef]
- Viennet, T.; et al. Structural insights from lipid-bilayer nanodiscs link alpha-Synuclein membrane-binding modes to amyloid fibril formation. Commun Biol 2018, 1, 44. [Google Scholar] [CrossRef]
- Guha, S.; Manna, T.K.; Das, K.P.; Bhattacharyya, B. Chaperone-like activity of tubulin. J Biol Chem 1998, 273, 30077–30080. [Google Scholar] [CrossRef]
- Choi, S.I.; et al. Protein solubility and folding enhancement by interaction with RNA. PLoS ONE 2008, 3, e2677. [Google Scholar] [CrossRef]
- Litberg, T.J.; Docter, B.; Hughes, M.P.; Bourne, J.; Horowitz, S. DNA Facilitates Oligomerization and Prevents Aggregation via DNA Networks. Biophys J 2020, 118, 162–171. [Google Scholar] [CrossRef] [PubMed]
- Barzegar, A.; Moosavi-Movahedi, A.A.; Mahnam, K.; Ashtiani, S.H. Chaperone-like activity of alpha-cyclodextrin via hydrophobic nanocavity to protect native structure of ADH. Carbohydr Res 2010, 345, 243–249. [Google Scholar] [CrossRef] [PubMed]
- Xie, L.; Jakob, U. Inorganic polyphosphate, a multifunctional polyanionic protein scaffold. J Biol Chem 2019, 294, 2180–2190. [Google Scholar] [CrossRef] [PubMed]
- Stumpf, M.P.; et al. Estimating the size of the human interactome. Proc Natl Acad Sci U S A 2008, 105, 6959–6964. [Google Scholar] [CrossRef]
- Heck, A.J. Native mass spectrometry: A bridge between interactomics and structural biology. Nat Methods 2008, 5, 927–933. [Google Scholar] [CrossRef]
- Rolland, T.; et al. A proteome-scale map of the human interactome network. Cell 2014, 159, 1212–1226. [Google Scholar] [CrossRef]
- Luck, K.; et al. A reference map of the human binary protein interactome. Nature 2020, 580, 402–408. [Google Scholar] [CrossRef]
- Hentze, M.W.; Castello, A.; Schwarzl, T.; Preiss, T. A brave new world of RNA-binding proteins. Nat Rev Mol Cell Biol 2018, 19, 327–341. [Google Scholar] [CrossRef]
- Miller, D.W.; Dill, K.A. Ligand binding to proteins: The binding landscape model. Protein Sci 1997, 6, 2166–2179. [Google Scholar] [CrossRef]
- Frankel, A.D.; Smith, C.A. Induced folding in RNA-protein recognition: More than a simple molecular handshake. Cell 1998, 92, 149–151. [Google Scholar] [CrossRef]
- Kumar, S.; Ma, B.; Tsai, C.J.; Sinha, N.; Nussinov, R. Folding and binding cascades: Dynamic landscapes and population shifts. Protein Sci 2000, 9, 10–19. [Google Scholar] [CrossRef] [PubMed]
- Wittung-Stafshede, P. Role of cofactors in protein folding. Acc Chem Res 2002, 35, 201–208. [Google Scholar] [CrossRef] [PubMed]
- Sanchez-Ruiz, J.M. Ligand effects on protein thermodynamic stability. Biophys Chem 2007, 126, 43–49. [Google Scholar] [CrossRef] [PubMed]
- Mu, X.; et al. Physicochemical code for quinary protein interactions in Escherichia coli. Proc Natl Acad Sci U S A 2017, 114, E4556–E4563. [Google Scholar] [CrossRef]
- Speer, S.L.; Stewart, C.J.; Sapir, L.; Harries, D.; Pielak, G.J. Macromolecular Crowding Is More than Hard-Core Repulsions. Annu Rev Biophys 2022, 51, 267–300. [Google Scholar] [CrossRef]
- Choi, S.I.; Son, A.; Lim, K.H.; Jeong, H.; Seong, B.L. Macromolecule-assisted de novo protein folding. Int J Mol Sci 2012, 13, 10368–10386. [Google Scholar] [CrossRef]
- Uhlen, M.; et al. Proteomics. Tissue-based map of the human proteome. Science 2015, 347, 1260419. [Google Scholar] [CrossRef]
- Chothia, C.; Gough, J.; Vogel, C.; Teichmann, S.A. Evolution of the protein repertoire. Science 2003, 300, 1701–1703. [Google Scholar] [CrossRef]
- Swatek, K.N.; Komander, D. Ubiquitin modifications. Cell Res 2016, 26, 399–422. [Google Scholar] [CrossRef]
- Geiss-Friedlander, R.; Melchior, F. Concepts in sumoylation: A decade on. Nat Rev Mol Cell Biol 2007, 8, 947–956. [Google Scholar] [CrossRef]
- Morelle, W.; Canis, K.; Chirat, F.; Faid, V.; Michalski, J.C. The use of mass spectrometry for the proteomic analysis of glycosylation. Proteomics 2006, 6, 3993–4015. [Google Scholar] [CrossRef] [PubMed]
- Pelham, H.R. Speculations on the functions of the major heat shock and glucose-regulated proteins. Cell 1986, 46, 959–961. [Google Scholar] [CrossRef] [PubMed]
- Craig, E.A.; Eisenman, H.C.; Hundley, H.A. Ribosome-tethered molecular chaperones: The first line of defense against protein misfolding? Curr Opin Microbiol 2003, 6, 157–162. [Google Scholar] [CrossRef] [PubMed]
- Maier, T.; Ferbitz, L.; Deuerling, E.; Ban, N. A cradle for new proteins: Trigger factor at the ribosome. Curr Opin Struct Biol 2005, 15, 204–212. [Google Scholar] [CrossRef]
- Schimmele, B.; Grafe, N.; Pluckthun, A. Ribosome display of mammalian receptor domains. Protein Eng Des Sel 2005, 18, 285–294. [Google Scholar] [CrossRef]
- Sorensen, H.P.; Kristensen, J.E.; Sperling-Petersen, H.U.; Mortensen, K.K. Soluble expression of aggregating proteins by covalent coupling to the ribosome. Biochem Biophys Res Commun 2004, 319, 715–719. [Google Scholar] [CrossRef]
- Brandt, F.; et al. The native 3D organization of bacterial polysomes. Cell 2009, 136, 261–271. [Google Scholar] [CrossRef]
- Tian, P.; et al. Folding pathway of an Ig domain is conserved on and off the ribosome. Proc Natl Acad Sci U S A 2018, 115, E11284–E11293. [Google Scholar] [CrossRef]
- Samelson, A.J.; Jensen, M.K.; Soto, R.A.; Cate, J.H.; Marqusee, S. Quantitative determination of ribosome nascent chain stability. Proc Natl Acad Sci U S A 2016, 113, 13402–13407. [Google Scholar] [CrossRef]
- Jensen, M.K.; Samelson, A.J.; Steward, A.; Clarke, J.; Marqusee, S. The folding and unfolding behavior of ribonuclease H on the ribosome. J Biol Chem 2020, 295, 11410–11417. [Google Scholar] [CrossRef]
- Esposito, D.; Chatterjee, D.K. Enhancement of soluble protein expression through the use of fusion tags. Curr Opin Biotechnol 2006, 17, 353–358. [Google Scholar] [CrossRef] [PubMed]
- Kapust, R.B.; Waugh, D.S. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 1999, 8, 1668–1674. [Google Scholar] [CrossRef] [PubMed]
- Paraskevopoulou, V.; Falcone, F.H. Polyionic Tags as Enhancers of Protein Solubility in Recombinant Protein Expression. Microorganisms 2018, 6, 47. [Google Scholar] [CrossRef] [PubMed]
- Smith, D.B.; Johnson, K.S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988, 67, 31–40. [Google Scholar] [CrossRef]
- Baker, R.T. Protein expression using ubiquitin fusion and cleavage. Curr Opin Biotechnol 1996, 7, 541–546. [Google Scholar] [CrossRef]
- Butt, T.R.; Edavettal, S.C.; Hall, J.P.; Mattern, M.R. SUMO fusion technology for difficult-to-express proteins. Protein Expr Purif 2005, 43, 1–9. [Google Scholar] [CrossRef]
- Santner, A.A.; et al. Sweeping away protein aggregation with entropic bristles: Intrinsically disordered protein fusions enhance soluble expression. Biochemistry 2012, 51, 7250–7262. [Google Scholar] [CrossRef]
- Kronqvist, N.; et al. Efficient protein production inspired by how spiders make silk. Nat Commun 2017, 8, 15504. [Google Scholar] [CrossRef]
- Bach, H.; et al. Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies. J Mol Biol 2001, 312, 79–93. [Google Scholar] [CrossRef]
- Basters, A.; et al. High yield expression of catalytically active USP18 (UBP43) using a Trigger Factor fusion system. BMC Biotechnol 2012, 12, 56. [Google Scholar] [CrossRef]
- Kyratsous, C.A.; Panagiotidis, C.A. Heat-shock protein fusion vectors for improved expression of soluble recombinant proteins in Escherichia coli. Methods Mol Biol 2012, 824, 109–129. [Google Scholar]
- Reddy, P.T.; O’Dell, W.B. Fusing an insoluble protein to GroEL apical domain enhances soluble expression in Escherichia coli. Methods Enzymol 2021, 659, 171–188. [Google Scholar] [PubMed]
- Ruan, A.; Ren, C.; Quan, S. Conversion of the molecular chaperone Spy into a novel fusion tag to enhance recombinant protein expression. J Biotechnol 2020, 307, 131–138. [Google Scholar] [CrossRef] [PubMed]
- Kim, C.W.; et al. N-terminal domains of native multidomain proteins have the potential to assist de novo folding of their downstream domains in vivo by acting as solubility enhancers. Protein Sci 2007, 16, 635–643. [Google Scholar] [CrossRef] [PubMed]
- Batey, S.; Clarke, J. The folding pathway of a single domain in a multidomain protein is not affected by its neighbouring domain. J Mol Biol 2008, 378, 297–301. [Google Scholar] [CrossRef]
- Kwon, S.B.; et al. Conversion of a soluble protein into a potent chaperone in vivo. Sci Rep 2019, 9, 2735. [Google Scholar] [CrossRef]
- Dill, K.A.; Ozkan, S.B.; Shell, M.S.; Weikl, T.R. The protein folding problem. Annu Rev Biophys 2008, 37, 289–316. [Google Scholar] [CrossRef]
- Jumper, J.; et al. Highly accurate protein structure prediction with AlphaFold. Nature 2021, 596, 583–589. [Google Scholar] [CrossRef]
- Baek, M.; et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science 2021, 373, 871–876. [Google Scholar] [CrossRef]
- Iadanza, M.G.; Jackson, M.P.; Hewitt, E.W.; Ranson, N.A.; Radford, S.E. A new era for understanding amyloid structures and disease. Nat Rev Mol Cell Biol 2018, 19, 755–773. [Google Scholar] [CrossRef]
- Ortega-Vinuesa, J.L.; et al. Colloidal Stability of Polymer Colloids with Different Interfacial Properties: Mechanisms. J Colloid Interface Sci 1996, 184, 259–267. [Google Scholar] [CrossRef] [PubMed]
- Moore, T.L.; et al. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chem Soc Rev 2015, 44, 6287–6305. [Google Scholar] [CrossRef] [PubMed]
- Rose, G.D. Protein folding - seeing is deceiving. Protein Sci 2021, 30, 1606–1616. [Google Scholar] [CrossRef] [PubMed]
- Sosnick, T.R.; Barrick, D. The folding of single domain proteins--have we reached a consensus? Curr Opin Struct Biol 2011, 21, 12–24. [Google Scholar] [CrossRef]
- Dill, K.A. Dominant forces in protein folding. Biochemistry 1990, 29, 7133–7155. [Google Scholar] [CrossRef]
- Rose, G.D.; Fleming, P.J.; Banavar, J.R.; Maritan, A. A backbone-based theory of protein folding. Proc Natl Acad Sci U S A 2006, 103, 16623–16633. [Google Scholar] [CrossRef]
- Rose, G.D. Reframing the Protein Folding Problem: Entropy as Organizer. Biochemistry 2021, 60, 3753–3761. [Google Scholar] [CrossRef]
- Danielsson, J.; et al. Global structural motions from the strain of a single hydrogen bond. Proc Natl Acad Sci U S A 2013, 110, 3829–3834. [Google Scholar] [CrossRef]
- Honig, B.H.; Hubbell, W.L. Stability of “salt bridges” in membrane proteins. Proc Natl Acad Sci U S A 1984, 81, 5412–5416. [Google Scholar] [CrossRef]
- Honig, B.H.; Hubbell, W.L.; Flewelling, R.F. Electrostatic interactions in membranes and proteins. Annu Rev Biophys Biophys Chem 1986, 15, 163–193. [Google Scholar] [CrossRef]
- Ramachandran, G.N.; Ramakrishnan, C.; Sasisekharan, V. Stereochemistry of polypeptide chain configurations. J Mol Biol 1963, 7, 95–99. [Google Scholar] [CrossRef] [PubMed]
- Davis, G.D.; Elisee, C.; Newham, D.M.; Harrison, R.G. New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol Bioeng 1999, 65, 382–388. [Google Scholar] [CrossRef]
- Zhang, Y.B.; et al. Protein aggregation during overexpression limited by peptide extensions with large net negative charge. Protein Expr Purif 2004, 36, 207–216. [Google Scholar] [CrossRef] [PubMed]
- Su, Y.; Zou, Z.; Feng, S.; Zhou, P.; Cao, L. The acidity of protein fusion partners predominantly determines the efficacy to improve the solubility of the target proteins expressed in Escherichia coli. J Biotechnol 2007, 129, 373–382. [Google Scholar] [CrossRef]
- Zou, Z.; et al. Hyper-acidic protein fusion partners improve solubility and assist correct folding of recombinant proteins expressed in Escherichia coli. J Biotechnol 2008, 135, 333–339. [Google Scholar] [CrossRef]
- Costa, S.; Almeida, A.; Castro, A.; Domingues, L. Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: The novel Fh8 system. Front Microbiol 2014, 5, 63. [Google Scholar] [CrossRef]
- Speed, M.A.; Wang, D.I.; King, J. Specific aggregation of partially folded polypeptide chains: The molecular basis of inclusion body composition. Nat Biotechnol 1996, 14, 1283–1287. [Google Scholar] [CrossRef]
- Rajan, R.S.; Illing, M.E.; Bence, N.F.; Kopito, R.R. Specificity in intracellular protein aggregation and inclusion body formation. Proc Natl Acad Sci U S A 2001, 98, 13060–13065. [Google Scholar] [CrossRef]
- Ryu, K.; et al. Assessment of substrate-stabilizing factors for DnaK on the folding of aggregation-prone proteins. Biochem Biophys Res Commun 2008, 373, 74–79. [Google Scholar] [CrossRef]
- Park, C.; et al. RNA-dependent proteome solubility maintenance in Escherichia coli lysates analysed by quantitative mass spectrometry: Proteomic characterization in terms of isoelectric point, structural disorder, functional hub, and chaperone network. RNA Biol 2024, 21, 1–18. [Google Scholar] [CrossRef]
- Grana-Montes, R.; Marinelli, P.; Reverter, D.; Ventura, S. N-terminal protein tails act as aggregation protective entropic bristles: The SUMO case. Biomacromolecules 2014, 15, 1194–1203. [Google Scholar] [CrossRef] [PubMed]
- Wayne, N.; Bolon, D.N. Charge-rich regions modulate the anti-aggregation activity of Hsp90. J Mol Biol 2010, 401, 931–939. [Google Scholar] [CrossRef] [PubMed]
- Huang, L.; et al. DAXX represents a new type of protein-folding enabler. Nature 2021, 597, 132–137. [Google Scholar] [CrossRef] [PubMed]
- De Los Rios, P.; Ben-Zvi, A.; Slutsky, O.; Azem, A.; Goloubinoff, P. Hsp70 chaperones accelerate protein translocation and the unfolding of stable protein aggregates by entropic pulling. Proc Natl Acad Sci U S A 2006, 103, 6166–6171. [Google Scholar] [CrossRef]
- Kellner, R.; et al. Single-molecule spectroscopy reveals chaperone-mediated expansion of substrate protein. Proc Natl Acad Sci U S A 2014, 111, 13355–13360. [Google Scholar] [CrossRef]
- Aoki, K.; et al. Calorimetric observation of a GroEL-protein binding reaction with little contribution of hydrophobic interaction. J Biol Chem 1997, 272, 32158–32162. [Google Scholar] [CrossRef]
- Joachimiak, L.A.; Walzthoeni, T.; Liu, C.W.; Aebersold, R.; Frydman, J. The structural basis of substrate recognition by the eukaryotic chaperonin TRiC/CCT. Cell 2014, 159, 1042–1055. [Google Scholar] [CrossRef]
- Koldewey, P.; Stull, F.; Horowitz, S.; Martin, R.; Bardwell, J.C.A. Forces Driving Chaperone Action. Cell 2016, 166, 369–379. [Google Scholar] [CrossRef]
- Horowitz, S.; Koldewey, P.; Stull, F.; Bardwell, J.C. Folding while bound to chaperones. Curr Opin Struct Biol 2018, 48, 1–5. [Google Scholar] [CrossRef]
- Hebert, D.N.; Foellmer, B.; Helenius, A. Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes. EMBO J 1996, 15, 2961–2968. [Google Scholar] [CrossRef]
- Ghosh, D.K.; Ranjan, A. The metastable states of proteins. Protein Sci 2020, 29, 1559–1568. [Google Scholar] [CrossRef] [PubMed]
- Narimoto, T.; et al. Conformational stability of amyloid fibrils of beta2-microglobulin probed by guanidine-hydrochloride-induced unfolding. FEBS Lett 2004, 576, 313–319. [Google Scholar] [CrossRef] [PubMed]
- Ciryam, P.; Kundra, R.; Morimoto, R.I.; Dobson, C.M.; Vendruscolo, M. Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases. Trends Pharmacol Sci 2015, 36, 72–77. [Google Scholar] [CrossRef] [PubMed]
- Coquerel, G. Crystallization of molecular systems from solution: Phase diagrams, supersaturation and other basic concepts. Chem Soc Rev 2014, 43, 2286–2300. [Google Scholar] [CrossRef]
- Tartaglia, G.G.; Pechmann, S.; Dobson, C.M.; Vendruscolo, M. Life on the edge: A link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci 2007, 32, 204–206. [Google Scholar] [CrossRef]
- Vecchi, G.; et al. Proteome-wide observation of the phenomenon of life on the edge of solubility. Proc Natl Acad Sci U S A 2020, 117, 1015–1020. [Google Scholar] [CrossRef]
- Hipp, M.S.; Hartl, F.U. Interplay of Proteostasis Capacity and Protein Aggregation: Implications for Cellular Function and Disease. J Mol Biol 2024, 436, 168615. [Google Scholar] [CrossRef]
- Linse, S.; Thalberg, K.; Knowles, T.P.J. The unhappy chaperone. QRB Discov 2021, 2, e7. [Google Scholar] [CrossRef]
- Abeln, S.; Frenkel, D. Disordered flanks prevent peptide aggregation. PLoS Comput Biol 2008, 4, e1000241. [Google Scholar] [CrossRef]
- Saunders, H.M.; et al. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein. Protein Sci 2011, 20, 1675–1681. [Google Scholar] [CrossRef]
- Crick, S.L.; Ruff, K.M.; Garai, K.; Frieden, C.; Pappu, R.V. Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation. Proc Natl Acad Sci U S A 2013, 110, 20075–20080. [Google Scholar] [CrossRef] [PubMed]
- Zhang, W.; et al. Modulation of the aggregation of an amyloidogenic sequence by flanking-disordered region in the intrinsically disordered antigen merozoite surface protein 2. Eur Biophys J 2019, 48, 99–110. [Google Scholar] [CrossRef] [PubMed]
- Ulamec, S.M.; Brockwell, D.J.; Radford, S.E. Looking Beyond the Core: The Role of Flanking Regions in the Aggregation of Amyloidogenic Peptides and Proteins. Front Neurosci 2020, 14, 611285. [Google Scholar] [CrossRef]
- Bhopatkar, A.A.; Kayed, R. Flanking regions, amyloid cores, and polymorphism: The potential interplay underlying structural diversity. J Biol Chem 2023, 299, 105122. [Google Scholar] [CrossRef]
- Robertson, A.L.; et al. Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation. Proc Natl Acad Sci U S A 2010, 107, 10424–10429. [Google Scholar] [CrossRef]
- Rutishauser, D.; et al. The comprehensive native interactome of a fully functional tagged prion protein. PLoS ONE 2009, 4, e4446. [Google Scholar] [CrossRef]
- Shirasaki, D.I.; et al. Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron 2012, 75, 41–57. [Google Scholar] [CrossRef]
- Blokhuis, A.M.; et al. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol 2016, 132, 175–196. [Google Scholar] [CrossRef]
- Tracy, T.E.; et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell 2022, 185, 712–728. [Google Scholar] [CrossRef]
- Holfeld, A.; et al. Systematic identification of structure-specific protein-protein interactions. Mol Syst Biol 2024, 20, 651–675. [Google Scholar] [CrossRef]
- Li, Q.X.; et al. Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer’s disease in human platelet and brain: Surface expression on the activated human platelet. Blood 1994, 84, 133–142. [Google Scholar] [CrossRef] [PubMed]
- Bai, Y.; et al. The in vivo brain interactome of the amyloid precursor protein. Mol Cell Proteomics 2008, 7, 15–34. [Google Scholar] [CrossRef] [PubMed]
- Maloney, B.; Lahiri, D.K. The Alzheimer’s amyloid beta-peptide (Abeta) binds a specific DNA Abeta-interacting domain (AbetaID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: Characterizing a new regulatory motif. Gene 2011, 488, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Zhou, C.; et al. Peripheral Lymphocytes in Primary Liver Cancers: Elevated NK and CD8+ T Cells and Dysregulated Selenium Metabolism. Biomolecules 2024, 14, 222. [Google Scholar] [CrossRef]
- Gestwicki, J.E.; Crabtree, G.R.; Graef, I.A. Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation. Science 2004, 306, 865–869. [Google Scholar] [CrossRef]
- Chiti, F.; et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci U S A 99 Suppl 2002, 4, 16419–16426. [Google Scholar] [CrossRef]
- Prudencio, M.; Hart, P.J.; Borchelt, D.R.; Andersen, P.M. Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease. Hum Mol Genet 2009, 18, 3217–3226. [Google Scholar] [CrossRef]
- Levitan, K.; et al. Conserved C-terminal charge exerts a profound influence on the aggregation rate of alpha-synuclein. J Mol Biol 2011, 411, 329–333. [Google Scholar] [CrossRef]
- Yang, X.; et al. On the role of sidechain size and charge in the aggregation of Abeta42 with familial mutations. Proc Natl Acad Sci U S A 2018, 115, E5849–E5858. [Google Scholar] [CrossRef]
- Baumer, K.M.; et al. Supercharging Prions via Amyloid-Selective Lysine Acetylation. Angew Chem Int Ed Engl 2021, 60, 15069–15079. [Google Scholar] [CrossRef]
- King, O.D.; Gitler, A.D.; Shorter, J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 2012, 1462, 61–80. [Google Scholar] [CrossRef] [PubMed]
- Kaushik, S.; Cuervo, A.M. Proteostasis and aging. Nat Med 2015, 21, 1406–1415. [Google Scholar] [CrossRef] [PubMed]
- Hipp, M.S.; Kasturi, P.; Hartl, F.U. The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol 2019, 20, 421–435. [Google Scholar] [CrossRef] [PubMed]
- Wright, P.E.; Dyson, H.J. Intrinsically disordered proteins in cellular signalling and regulation. Nat Rev Mol Cell Biol 2015, 16, 18–29. [Google Scholar] [CrossRef]
- Uversky, V.N.; et al. Unfoldomics of human diseases: Linking protein intrinsic disorder with diseases. BMC Genomics 2009, 10 (Suppl. 1), S7. [Google Scholar] [CrossRef]
- Uversky, V.N. How to drug a cloud? Targeting intrinsically disordered proteins. Pharmacol Rev 2024. [CrossRef]
- Hardy, J.A.; Higgins, G.A. Alzheimer’s disease: The amyloid cascade hypothesis. Science 1992, 256, 184–185. [Google Scholar] [CrossRef]
- Ringe, D.; Petsko, G.A. What are pharmacological chaperones and why are they interesting? J Biol 2009, 8, 80. [Google Scholar] [CrossRef]
- Liguori, L.; et al. Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations. Int J Mol Sci 2020, 21, 489. [Google Scholar] [CrossRef]











Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).